Tiziana Life Sciences (Tiziana Life Sciences) Change In Receivables : $-1.52 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Tiziana Life Sciences Change In Receivables?

Tiziana Life Sciences's change in receivables for the quarter that ended in Dec. 2023 was $0.51 Mil. It means Tiziana Life Sciences's Accounts Receivable declined by $0.51 Mil from Jun. 2023 to Dec. 2023 .

Tiziana Life Sciences's change in receivables for the fiscal year that ended in Dec. 2023 was $-1.52 Mil. It means Tiziana Life Sciences's Accounts Receivable increased by $1.52 Mil from Dec. 2022 to Dec. 2023 .

Tiziana Life Sciences's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tiziana Life Sciences's liquidation value for the six months ended in Dec. 2023 was $-5.47 Mil.

Tiziana Life Sciences Change In Receivables Historical Data

The historical data trend for Tiziana Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tiziana Life Sciences Change In Receivables Chart

Tiziana Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-0.13

-0.47

-0.09

-1.16

-1.52

Tiziana Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-0.15	-1.01	-2.03	0.51

Tiziana Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.52 Mil.

Tiziana Life Sciences (NAS:TLSA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tiziana Life Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Tiziana Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Tiziana Life Sciences's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.183	-	6.648	+	0.75 * 0	+	0.5 * 0
=	-5.47

Tiziana Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tiziana Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tiziana Life Sciences (Tiziana Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tiziana Life Sciences Ltd (NAS:TLSA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

0RP:Germany

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM 11

Website

https://www.tizianalifesciences.com

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience.